Imidocarb Dihydrochloride is a urea derivative used extensively in veterinary medicine as an effective antiprotozoal agent to treat infections such as babesiosis caused by Babesia and other related parasites.… Read more
Imidocarb Dihydrochloride is a urea derivative used extensively in veterinary medicine as an effective antiprotozoal agent to treat infections such as babesiosis caused by Babesia and other related parasites. By disrupting the energy metabolism of protozoan organisms, this compound halts their replication and growth within host cells. Laboratories involved in veterinary pharmaceutical research require high-quality reference standards for Imidocarb Dihydrochloride, including its pharmacopeial and non-pharmacopeial impurities, to ensure accurate analytical results. These standards are critical for impurity profiling, method validation, and rigorous quality control testing. Furthermore, stable isotope labelled compounds are often employed as internal standards in mass spectrometry workflows, enabling precise quantification of the drug and its metabolites in complex biological matrices. Utilizing these analytical tools ensures compliance with regulatory standards and maintains the integrity of drug product assessments throughout the development and manufacturing lifecycle.